A comparison between fibronectin and Matrigel pretreated ePTFE vascular grafts.
Two distinct series of experiments were performed to compare the behavior of ePTFE vascular grafts coated with basement membrane gel to that of identical grafts coated with fibronectin. Bilateral carotid interposition grafts (10 cm long) were interposed in 16 conditioned mongrel dogs. In the first series of experiments (n = 10), each graft was seeded with radiolabeled endothelial cells and initial endothelial cell adherence was determined. Following restoration of blood flow in the grafts, endothelial cell retention was measured for 24 hours. Seeding efficiency was 66.48% (+/- 13.2) for fibronectin-coated grafts and 56.58% (+/- 13.51) for gel-coated grafts. There was a slow, constant loss of activity during the first 90 minutes of imaging, and at 24 hours of observation the activity remaining on the fibronectin-coated graft was 13.2 +/- 3.98% of the initial graft activity. Although the basement membrane gel had a higher mean activity at 24 hours (18.9 +/- 7.22%), the difference was not statistically significant at any interval. In the second series of animals (n = 6), radiolabeled platelets were injected within 60 minutes following restoration of flow. Total platelet activity on the explanted grafts was 3.36 (+/- 1.35) x 10(5) counts per gram/0.2 minute for the fibronectin-coated grafts. The gel-coated grafts had 2.74 (+/- 1.33) x 10(5) counts per gram/0.2 minute, a difference that was not statistically significant. Thus, despite its theoretical appeal, basement membrane gel was no better than fibronectin in increasing endothelial cell adherence and retention, and the resulting flow surface of grafts treated with either compound appeared to attract platelets to an equal degree.
Patterson
R B
RB
Department of Surgery, University of Cincinnati Medical Center, Ohio 45267-0558.
Keller
J D
JD
Silberstein
E B
EB
Kempczinski
R F
RF
D000818:Animals; D001485:Basement Membrane; D001807:Blood Vessel Prosthesis; D002448:Cell Adhesion; D003094:Collagen; D004285:Dogs; D004338:Drug Combinations; D004730:Endothelium, Vascular / Q000166:cytology* / Q000378:metabolism; D005353:Fibronectins; D007700:Kinetics; D007797:Laminin; D010973:Platelet Adhesiveness; D011138:Polytetrafluoroethylene; D011474:Prosthesis Design; D011509:Proteoglycans
D004338:Drug Combinations; D005353:Fibronectins; D007797:Laminin; D011509:Proteoglycans; C059485:matrigel; D011138:Polytetrafluoroethylene; D003094:Collagen